Sofinnova Investments is a leading venture capital firm specializing in life sciences and biotechnology investments. The firm focuses on transformative biotech companies from inception through IPO, providing support in drug development, regulatory processes, and company building. Sofinnova's investment strategy spans various stages, with a particular emphasis on Series A to Series C rounds.
Sofinnova's portfolio includes notable companies such as Invitae, Natera, and Coherus BioSciences. The firm's collaborative approach and experienced team offer valuable guidance to portfolio companies throughout their growth journey. Sofinnova's commitment to funding tomorrow's cures positions them as a key player in advancing innovative healthcare solutions and biotechnology breakthroughs.
Sofinnova Investments - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments108
Current Portfolio Count47
Total Portfolio Exits5
Top Investment Stages
Series A29 (29.9%)
Series B22 (22.7%)
Series Unknown22 (22.7%)
Series C16 (16.5%)
Series D8 (8.2%)
Stage Mix
Series A 30%Series B 23%Series Unknown 23%Series C 16%Series D 8%
Concentration shown as share of disclosed investments by stage.
Sofinnova Investments - Classification
- Also Known As
- Sofinnova Investments, Inc.
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end